ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Study Evaluating the Safety and Efficacy of Two Concentrations (0.4% and 1%) of ALY688 Ophthalmic Solution in Subjects with Dry Eye Disease
Epistemonikos ID: 177e272a2eef33a6ae6163ff67577fc806255231
First added on: May 08, 2024